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Nephrogenesis occurs predominantly in late gestation at a time when preterm infants are 33 
already delivered.  The aims of this study were to assess the effect of preterm birth and 34 
the effect of antenatal glucocorticoid treatment on nephrogenesis.   Preterm baboons, 35 
which were delivered at 125 days gestation and ventilated for up to 21 days postnatally, 36 
were compared to gestational controls.  A cohort of preterm baboons that had been 37 
exposed to antenatal glucocorticoids were compared to unexposed preterm baboons.  The 38 
number of glomerular generations was estimated using a medullary ray glomerular 39 
counting method and glomerular number estimated using unbiased stereology.  CD31 and 40 
WT-1 localisation was examined using immunohistochemistry and VEGF was localised 41 
using in situ hybridisation.  The number of glomerular generations was not affected by 42 
preterm birth and total glomerular numbers were within the normal range.  Kidneys were 43 
significantly enlarged in preterm baboons with a significant decrease in glomerular 44 
density (number of glomeruli per gram of kidney) in the preterm kidney as compared to 45 
gestational controls.  Neonates exposed to antenatal steroids had an increased kidney-to-46 
body weight ratio and also more developed glomeruli compared to unexposed controls.  47 
Abnormal glomeruli, with a cystic Bowman’s space and shrunken glomerular tuft, were 48 
often present in the superficial renal cortex of both the steroid exposed and unexposed 49 
preterm kidneys; steroid exposure had no significant effect on the proportion of abnormal 50 
glomeruli.   The proportion of abnormal glomeruli in the preterm kidneys ranged from 51 
0.2% - 18%.  In conclusion, although nephrogenesis is on-going in the extrauterine 52 
environment our findings demonstrate that preterm birth, independent of steroid-53 




neonatal kidneys.  Whether final nephron endowment is affected in those kidneys 55 
exhibiting a high proportion of abnormal glomeruli is yet to be confirmed.  56 








The incidence of preterm birth is currently high, with 13% of all babies born preterm in 62 
the United States (17) and 8% in Australia (25).  In addition, the survival of preterm 63 
infants, including extremely preterm infants has improved substantially over recent years 64 
such that infants born as early as 26 weeks of gestation now have a 60-80% chance of 65 
survival (28, 34).   66 
In the human kidney, nephrogenesis commences at around the 5th week of gestation and 67 
is complete by 36 weeks gestation (32).  After this point, no more new nephrons are 68 
formed for the life of the individual.  Nephrogenesis predominantly occurs in late 69 
gestation at a time when preterm infants are already delivered (20).  It is important to 70 
gain an understanding of the effects of preterm birth on nephrogenesis since there is 71 
accumulating epidemiological data linking premature birth with an increased incidence of 72 
hypertension (8, 22) and adverse renal function (23) later in life; this may be linked to a 73 
reduced nephron endowment after birth (4). 74 
To our knowledge there has only been one previously published study which has 75 
investigated the effects of preterm birth on nephrogenesis.  In the autopsy study, 76 
conducted by Rodriguez et al. (31), a reduced number of glomerular generations, 77 
potentially indicative of a nephron deficit, was reported in kidneys of infants that were 78 
born preterm.  It is important to note, however, that the cohort of preterm infants in the 79 
human autopsy study included a number of infants that were not only preterm but also 80 
intrauterine growth restricted (IUGR).  Since it is well known that IUGR adversely 81 




preterm birth and IUGR on nephrogenesis in the previous study.  In addition, any 83 
abnormal effects observed in the human autopsied kidneys may have been a direct result 84 
of a failure of the baby to thrive after birth rather than preterm birth per se.  Hence in this 85 
study we have examined the effects of preterm birth, in the absence of IUGR, in a non-86 
human primate model where the neonates were in relatively good health after birth.  87 
The improved survival of preterm neonates, such as those born as early as 27 weeks 88 
gestation, can be largely attributed to the use of antenatal glucocorticoids. These have 89 
been shown to accelerate lung maturation, thus reducing neonatal morbidity and mortality 90 
(11).  Previous experimental studies have demonstrated a link between glucocorticoid 91 
exposure early in utero and a reduction in nephron endowment (5, 30, 38) . There is no 92 
evidence to date, however, as to the effects of clinical doses of antenatal glucocorticoids 93 
on nephrogenesis.   94 
Hence, the aims of the current study were to firstly assess the effects of preterm birth on 95 
nephrogenesis and secondly, to determine the effects of prenatal glucocorticoid treatment 96 
on nephrogenesis.  To address these aims we have used a baboon (non-human primate) 97 
model, where the ontogeny of the kidney closely resembles that of the human (18) and 98 
the preterm neonates are cared for in a neonatal intensive care unit after birth in a similar 99 
manner as human infants (6).  In our model, the baboons are delivered at 125 days of 100 
gestation (0.67 of total length of gestation), a time point at which nephrogenesis is still 101 
on-going in the baboon (18) and is approximately equivalent to 27 weeks of gestation in 102 










INDUCTION OF PRETERM DELIVERY AND POSTNATAL CARE 110 
All animal experiments were undertaken at the Southwest Foundation for Biomedical 111 
Research, San Antonio, Texas.  All animal handling procedures were approved to 112 
conform to the American Association for Accreditation of Laboratory Animal Care 113 
guidelines.  Fetal baboons were delivered prematurely by caesarean section at 125 days 114 
gestation (Term=185 days).  After birth, all preterm neonates were intubated, 115 
administered 100 mg/kg surfactant (Survanta; donated by Ross Products, Columbus, OH, 116 
USA) and were ventilated with pressure-limited infant ventilators (InfantStar; donated by 117 
Infrasonics, San Diego, CA, U.S.A).  All preterm neonates were also treated with 118 
ampicillin and gentamycin for the first 7-10 days of life.  Further doses of antibiotics 119 
were only administered in cases of clinically suspected infection; two preterm animals 120 
were administered additional doses of vancomycin and a cephalosporin antibiotic, Fortaz 121 
(day 10-13 of life in one preterm neonate and day 10-17 of life in the other preterm 122 
neonate).   123 
A detailed description of the postnatal clinical and nutritional management of the preterm 124 
baboons has been previously published (39).  Briefly, during the first 24 hours of life, all 125 
animals received heparinised normal saline and 5% dextrose/water and supplemental 126 
calcium infusion.  Sufficient fluids were administered in order to maintain electrolyte 127 
homeostasis, a minimal urine output of 1-2 ml/kg/h and blood pressure within the normal 128 
range.  Parenteral nutrition was initiated at 24 hours of life with amino acids, electrolytes, 129 
vitamins and trace elements.  If clinically stable, enteral nutrition was initiated on day 7 130 




gastric infusion and once 100 ml/kg/day was tolerated, feeds were changed to Primilac 132 
(Bio-Serv, Frenchtown, NJ, U.S.A).  Serum electrolytes, glucose and hematocrit were 133 
maintained within the normal range for the extremely low birth weight infant. 134 
None of the animals had, or required, Foley catheters or any other form of urinary 135 
drainage device.  There were also no animals that had identifiable urinary tract anomalies 136 
or obstructions at the time of necropsy.   137 
THE EFFECT OF PRETERM BIRTH ON NEPHROGENESIS IN THE 138 
CONTEXT OF ANTENATAL STEROIDS 139 
Fetal baboons were delivered prematurely by caesarean section at 125 days gestation 140 
(term=185).  Neonates were euthanized at delivery (125 days gestation; n=4; 2 males and 141 
2 females) or maintained in intensive care for 6 days (n=2; all males), 14 days (n=2; all 142 
males), or 21 days (Preterm + 21 days; n=4; all males) before being euthanized.  143 
Gestational-age-matched controls for the Preterm + 21 days group were delivered and 144 
euthanized at 146 days gestation (n=4; 3 males and 1 female).  All animals in the Preterm 145 
+ 21 days group and the 125 and 146 day gestational control groups were exposed to 146 
antenatal maternal steroids in utero.  In those animals, pregnant baboons weighing 147 
approximately 15 kg received 6 mg betamethasone (Celestone Soluspan; Schering 148 
Pharmaceuticals, Kenilworth, NJ, USA) by intramuscular injection at 123 and 124 days 149 
of gestation (a dose of approximately 0.4 mg/kg/day) (24, 33).  Those same animals were 150 
compared to non-betamethasone exposed controls in the subsequent study described 151 
below.   It is to be noted that only individual data is shown for the baboons euthanized at 152 
6 and 14 days and they were only included in the linear regression analyses; these 153 




gestation (175 and 185 days; n=5; 4 males and 1 female) were used for comparison when 155 
looking at the number of glomerular generations formed within the kidney.  Previously, 156 
we have shown that nephrogenesis in the baboon is on-going at 125 days gestation and 157 
complete by 175 days gestation (18), so the kidneys from the 175 and 185 day gestational 158 
control groups were combined.   159 
THE EFFECT OF PRENATAL MATERNAL GLUCOCORTICOIDS ON 160 
NEPHROGENESIS  161 
The four betamethasone-exposed baboons euthanized at 125 days gestation (utilized in 162 
the study described above) were compared to non-betamethasone exposed controls (125 163 
days gestation; n=6; 3 males and 3 females).  The four betamethasone-exposed preterm 164 
neonates maintained for 21 days postnatally (utilized in the study described above) were 165 
compared to preterm controls (not exposed to antenatal betamethasone) at postnatal day 166 
21 (Preterm + 21 days; n=4; 2 males and 2 females).    At postnatal day 21, the baboons 167 
were euthanized. 168 
TISSUE PROCESSING, EMBEDDING AND SECTIONING 169 
Kidneys were immersion-fixed at necropsy, cut into halves, sliced into 2 mm slices and 170 
sampled using a smooth fractionator approach (29).  The sampled slices (8-15 slices per 171 
kidney) were embedded in glycolmethacrylate to be used for the estimation of the 172 
number of glomeruli, the number of glomerular generations, kidney volume, mean renal 173 
corpuscle volume and the proportion of abnormal glomeruli.  Complete slices containing 174 
both cortex and medulla were randomly selected from the remaining slices, embedded in 175 
paraffin and sectioned at five μm for the immunohistochemical analyses. 176 





Morphological assessment of nephrogenesis  179 
The presence of undifferentiated metanephric mesenchyme, the branching ureteric bud, 180 
and developing glomerular structures in the form of Comma- and S-shaped bodies in the 181 
outer cortex indicated that nephrogenesis was on-going.  Developed glomeruli exhibited a 182 
well defined glomerular tuft surrounded by a distinct Bowman’s space and capsule.   183 
Measurement of nephrogenic zone thickness 184 
The width of the nephrogenic zone was measured using image analysis software (Image 185 
Pro Plus v. 6.0 for Windows, Media Cybernetics; Silver Spring, MD, USA).  This method 186 
was based on a previous method used to measure nephrogenic zone thickness to assess 187 
renal maturity in human neonatal kidneys (9, 12).  From the serially sectioned 188 
glycolmethacrylate sections, one complete intact section from each sampled kidney slice 189 
(8-15 complete sections per kidney) was used to estimate the width of the nephrogenic 190 
zone.  Each section was viewed at 200X magnification and the width of the nephrogenic 191 
zone was measured in 3 separate regions of each kidney section.  The nephrogenic zone 192 
was defined as the area in the outer renal cortex exhibiting developing glomerular 193 
structures in the form of Comma and S-shaped bodies.  An average nephrogenic zone 194 
width was determined for each kidney.     195 
Estimation of glomerular generation number   196 
One complete intact section from each glycolmethacrylate block (8-15 blocks per kidney) 197 
was examined.  In each sampled section five clearly distinguishable medullary rays from 198 
separate regions were identified.  The number of developed glomeruli (inclusive of 199 
normal and abnormal glomeruli) along one side of each medullary ray were counted, and 200 




Estimation of the number of developed glomeruli, kidney volume and mean renal 202 
corpuscle volume   203 
Glycolmethacrylate blocks (8-15 per kidney) were serially sectioned at 20 μms with 204 
every 10th and 11th sections collected and stained with H&E.  Kidney volume was then 205 
estimated using the Cavalieri principle (29).  One pair of complete intact sections from 206 
each block was used for the estimation of glomerular number.  Using an unbiased 207 
physical disector/fractionator technique, renal corpuscle volume and the number of 208 
glomeruli (and thereby nephrons) in the kidneys were stereologically estimated (3, 18).  209 
In the counting of glomeruli, only developed glomeruli (inclusive of normal and 210 
abnormal glomeruli) exhibiting a well defined Bowman’s space and capsule were 211 
included; developing glomerular structures such as Comma-shaped and S-shaped bodies 212 
were not counted.  213 
 214 
CHARACTERISATION OF ABNORMAL GLOMERULI 215 
Quantitative assessment of abnormal glomeruli  216 
Whilst undertaking the stereological estimation of glomerular number, in each field of 217 
view the number of normal and abnormal glomeruli (exhibiting a shrunken glomerular 218 
tuft and dilated Bowman’s space) was recorded and the percentage of abnormal glomeruli 219 
within the whole kidney was determined. 220 
Immunohistochemical analysis with the endothelial cell marker, CD31 and podocyte 221 
marker, Wilms-tumour suppressor gene-1 (WT-1)   222 
Five μm paraffin sections were de-paraffinized, re-hydrated and rinsed in water and 10 223 




microwave) was undertaken in Tris-EDTA buffer (10mM Tris Base, 1mM EDTA, 0.05% 225 
Tween 20; pH 9.0).  Endogenous peroxidase activity was blocked by placing slides in an 226 
endogenous enzyme block solution (Dako, CA, U.S.A) for 15 minutes.  Sections were 227 
then incubated with 1% goat serum for 20-30 minutes.  Subsequently, sections were 228 
incubated with the primary antibody, either a mouse anti-human CD31 monoclonal 229 
antibody (1:15 dilution) (JC70A; Dako, California) or a mouse anti-human WT-1 230 
monoclonal antibody (1:100 dilution) (M3561; Dako, CA, U.S.A) overnight.  The 231 
negative control consisted of a mouse IgG antibody raised against bacterial glucose 232 
oxidase (Dako, CA, U.S.A).  The sections were then incubated for 2 hours with the 233 
‘Envision’ molecule (Dako, CA, U.S.A), and 3’3’-diaminobenzidine tetrachloride (DAB) 234 
was used to detect antibody binding.  All sections were counterstained with hematoxylin. 235 
In situ hybridization of vascular endothelial growth factor ( VEGF) mRNA        236 
For the synthesis of riboprobes, a cDNA fragment of human VEGF121 (gift of Steven 237 
Stacker, Ludwig Institute, Melbourne, Australia) was cloned into BSKS plasmid 238 
(Stratagene, La Jolla, CA, U.S.A) and linearized with HindIII.  An anti-sense riboprobe 239 
was generated from the template incorporating DIG-UTP (Roche Applied Science, 240 
Mannheim, Germany) into run off transcripts using T7 RNA polymerase. A sense 241 
riboprobe was also generated. In-situ hybridization was undertaken in 4µm paraffin 242 
sections as described by Sutherland et al. (36).   243 
 244 
STATISTICAL ANALYSIS 245 
Statistical analyses were performed using GraphPad Prism Version 4.0 for Windows 246 




utilized to compare data between the 125 day and 146 day gestational control groups, and 248 
the Preterm +21 days group.  This was followed by a Tukey’s post-hoc analysis. 249 
Data between steroid exposed and unexposed neonates were analysed using a Student’s t-250 
test.  In order to compare data between steroid exposed and unexposed neonates from 251 
different post-conceptional time points, a two-way analysis of variance was utilized.  252 
Physiological data was analysed using a repeated measures two-way analysis of variance 253 
followed by a Bonferroni’s post-hoc analysis.   254 
Linear regression analyses were performed to determine if there were significant 255 
correlations between glomerular number and post-conceptional age, birth weight, kidney 256 
weight, kidney volume and renal corpuscle volume.  Included in these analyses was data 257 
from steroid exposed and unexposed animals and animals from the Preterm + 6 days and 258 
Preterm + 14 days groups.  An analysis of covariance was used to determine any 259 
differences in the linear regressions between the preterm group and the gestational 260 





THE EFFECT OF PRETERM BIRTH ON NEPHROGENESIS IN THE 263 
CONTEXT OF ANTENATAL STEROIDS 264 
Postnatal fetal physiology  265 
Arterial blood gases (pH, PaCO2, PaO2), fluid intake, urine output and mean arterial 266 
blood pressure of preterm neonates from birth until postnatal day 21 were all within 267 
the accepted clinical range.  268 
Body weights, kidney weights and kidney volumes  269 
All fetal baboons had birth weights above the 10% reference range for premature 270 
baboons delivered at this gestational time point.  There was no significant difference 271 
in birth weights between the 125 day gestational control group and the Preterm + 21 272 
days group (Table 1).  Necropsy weights of the Preterm + 21 days group were 273 
significantly less (P=0.002) compared to the 146 day gestational-age-matched 274 
controls.  Although all preterm baboons lost weight after birth, relative kidney 275 
weights and volumes were significantly increased compared to the 125 and 146 day 276 
gestational controls.   277 
Assessment of nephrogenesis   278 
In the preterm kidneys at postnatal day 6, 14 and 21 and in the 125 and 146 day 279 
gestational controls, there was morphological evidence of on-going nephrogenesis 280 
(Figure 1A).  In the preterm kidneys at postnatal day 21, nephrogenic zone thickness 281 
was significantly less compared to the 125 day gestational control group but not 282 
significantly different to the 146 day gestational control group (Figure 1B). 283 
The number of glomerular generations increased significantly from 125 days gestation 284 
to 175/185 days gestation (Figure 1C).  The number of glomerular generations in the 285 




in the 146 day gestational-age-matched controls, and was significantly higher than the 287 
125 days group. 288 
In accordance with the glomerular generation data, the number of developed 289 
glomeruli in the Preterm + 21 days group was significantly greater compared to the 290 
125 day gestational controls, but was not significantly different to the 146 day 291 
gestational age-matched controls (Table 1).   292 
Statistically significant correlations were found between glomerular number and post-293 
conceptional age (r2=0.781, P=0.0001) and between glomerular generations and post-294 
conceptional age (r2=0.613, P=0.003) when all preterm animals were combined 295 
(Figure 1D-E).  In the two kidneys from the Preterm + 6 days group, there were 296 
184,234 and 202,316 developed glomeruli and in the kidneys from postnatal day 14 297 
(n=2) there were 140,185 and 178,661 developed glomeruli.    298 
Birth weight correlated significantly with glomerular number in both the preterm 299 
neonates (r2=0.438, P=0.02) and the gestational controls (r2=0.680, P=0.01).  In the 300 
preterm neonates, there was no significant correlation between necropsy weight and 301 
glomerular number.   302 
Importantly, there was a very strong correlation between kidney weight and 303 
glomerular number in both the preterm neonates (r2=0.703, P=0.0007) and gestational 304 
controls (r2=0.664, P=0.01); however, there was a significant difference in the slopes 305 
of the regression lines (P=0.048) such that in the preterm kidneys there were 83,840 306 
glomeruli/gram, compared to 193,400 glomeruli/gram in the gestational controls 307 
(Figure 2).  308 
There was no significant difference in the mean renal corpuscle volume between the 309 




(Table 1).  There was no significant correlation between renal corpuscle volume and 311 
glomerular number. 312 
THE EFFECT OF PRENATAL MATERNAL GLUCOCORTICOIDS ON 313 
NEPHROGENESIS 314 
Postnatal fetal physiology 315 
Exposure to antenatal maternal glucocorticoids at 123 and 124 days gestation did not 316 
significantly affect arterial blood gas levels (pH, PO2, PCO2) following preterm 317 
delivery at 125 days gestation (Table 2).  There was no significant difference in fluid 318 
intake or urine output between the two groups (Figure 3A-B).  At 72 hours of life, 319 
however, mean arterial blood pressure was significantly elevated in the steroid 320 
exposed group (P<0.05) (Figure 3C).  There was no significant difference in mean 321 
arterial blood pressure between the two groups at postnatal day 21.   322 
Body weights, kidney weights and kidney volumes  323 
Antenatal exposure to steroids (123 and 124 days gestation) did not affect fetal birth 324 
weight at 125 days gestation, necropsy weight at postnatal day 21, or absolute kidney 325 
weights or kidney volumes (Table 3).  Kidney weight-to-body weight ratio, however, 326 
was significantly greater in the animals exposed to antenatal steroids (P=0.02). 327 
Assessment of nephrogenesis 328 
There were no apparent morphological differences in kidney structure between the 329 
steroid exposed and unexposed preterm groups at postnatal day 21.  Kidneys from 330 
both the Preterm + 21 days group and the Preterm + 21 days + steroids group 331 
exhibited a clearly visible nephrogenic zone and there was no significant difference in 332 
the width of the nephrogenic zones (94.2±6.5 μm versus 100.5±10.6 μm, 333 
respectively).   334 




There was no difference in the number of glomerular generations formed within the 336 
kidney between the steroid exposed and unexposed groups (Table 3).  337 
There was a significant increase in the number of developed glomeruli in the steroid 338 
exposed kidneys (Table 3).  The number of developed glomeruli was 9% higher in the 339 
steroid exposed kidneys compared to unexposed controls at 125 days gestation, and 340 
27% higher at postnatal day 21.   341 
The response of renal corpuscle volume in relation to maternal steroid treatment was 342 
different in kidneys at 125 days gestation compared to preterm kidneys at postnatal 343 
day 21 (Table 3).  At 125 days gestation there was a significant increase in renal 344 
corpuscle volume whereas on postnatal day 21 there was a significant decrease.   345 
 346 
CHARACTERISATION OF ABNORMAL GLOMERULI  347 
We observed in many of the preterm kidneys (both steroid exposed and unexposed), 348 
at all postnatal time points, the presence of abnormal glomeruli; these were grossly 349 
enlarged and exhibited a cystic Bowman’s space and shrunken glomerular tuft.  The 350 
abnormal glomeruli were only located in the outer renal cortex and exhibited an 351 
immature morphology; the clearly recognizable glomerular anlage was surrounded by 352 
a cup-shaped layer of epithelial cells.   353 
Quantitative assessment of abnormal glomeruli 354 
There was a wide variation in the proportion of abnormal glomeruli within the 355 
preterm kidneys (Table 4 and 5); steroid exposure did not affect the proportion of 356 
abnormal glomeruli in the kidney.  The proportion of abnormal glomeruli in the 357 
preterm kidneys ranged from 0.2% to 18.3%.  Of the twelve preterm kidneys analyzed 358 
(inclusive of steroid exposed and unexposed), 50% had more than 4% of their 359 




glomeruli was greater than 10%.  In one of the preterm baboons the morphology of 361 
the kidney was grossly abnormal with 18% of the glomeruli abnormal.  The 362 
proportion of abnormal glomeruli in the kidneys of the gestational controls was 363 
considered negligible (Table 4).         364 
Immunohistochemical localization of the endothelial cell marker, CD31 (Figure 365 
4A) 366 
In kidney sections at 146 days gestation, the well developed glomeruli adjacent to the 367 
nephrogenic zone demonstrated profuse positive staining for CD31.  In the preterm 368 
kidneys, the abnormal glomeruli exhibited little CD31 immunostaining compared to 369 
well developed glomeruli observed in the same section.   370 
Immunohistochemical localisation of the podoctye marker, WT-1 (Figure 4B) 371 
Profuse WT-1 staining was observed in the glomerular tuft of well developed, normal 372 
glomeruli from preterm kidneys. In the abnormal glomeruli from the preterm kidneys, 373 
however, WT-1 positive immunostaining was localised to the layer of epithelial cells 374 
surrounding the spherical mass of cells of the glomerular tuft.  Positive 375 
immunostaining was also localised to the epithelial cells of the Bowman’s capsule in 376 
the abnormal glomeruli.   377 
In situ localisation of vascular endothelial growth factor, VEGF mRNA (Figure 378 
4C) 379 
 VEGF mRNA was localised to the glomerular podocytes in both the preterm kidneys 380 






The findings of this study clearly demonstrate that nephrogenesis continues after 384 
preterm birth in the steroid exposed and unexposed primate kidney.  There was an 385 
increase in the number of glomerular generations and total glomeruli in the 386 
extrauterine environment, with no differences found between the preterm kidneys and 387 
their gestational age matched controls, in the context of antenatal steroids.  388 
Interestingly, exposure to antenatal glucocorticoids prior to preterm birth led to renal 389 
hypertrophy and an increase in the number of developed glomeruli in the kidney 390 
compared to unexposed kidneys.  Many of the glomeruli located in the outer renal 391 
cortex of the preterm kidney, in both the steroid exposed and unexposed baboon 392 
neonates, often appeared abnormal.  Immunohistochemical analyses of these 393 
abnormal glomeruli showed that they were in a relatively immature state of 394 
development, poorly vascularized and are therefore likely to be non-functional.  395 
 396 
Although all preterm baboons lost weight after birth, there appeared to be substantial 397 
postnatal kidney growth, with the relative kidney weights and kidney volumes 398 
significantly higher in the preterm animals compared to the gestational controls.  399 
Similar findings have been previously reported in preterm babies (21).  The renal 400 
hypertrophy observed in the preterm kidneys did not appear to be attributed to 401 
differences in the thickness of the nephrogenic zone or in the size of glomeruli thus 402 
implying tubular hypertrophy.       403 
 404 
Our results demonstrate that nephrogenesis unequivocally occurs postnatally in both 405 
steroid exposed and unexposed preterm neonates; morphologically there was evidence 406 




generations and the total number of developed glomeruli increased with postnatal age.  408 
The average number of developed glomeruli in the preterm kidneys (inclusive of 409 
steroid exposed and unexposed preterm kidneys) was approximately 245,673, ranging 410 
from 138,078 to 304,186, which appears to be within the normal range for term 411 
baboon kidneys, albeit at the lower end (18).  Total glomerular number is also 412 
expected to increase further since nephrogenesis, although nearing completion was 413 
not finished by postnatal day 21.   414 
 415 
In the context of antenatal steroids, there was no significant difference in the number 416 
of glomerular generations formed in the kidney between the Preterm + 21 day kidneys 417 
and their 146 day gestational-age-matched controls.  These findings are not consistent 418 
with those of Rodriguez et al. (31) where they reported fewer glomerular generations 419 
within the kidneys of autopsied preterm infants.  However, the discrepancy in findings 420 
is likely explained by a number of the preterm human neonates being intrauterine 421 
growth restricted in the study of Rodriguez et al. (31), which is known to influence 422 
nephron endowment (19, 40).   423 
 424 
We have previously reported a very strong correlation between renal size and 425 
glomerular number (18) and this association appears to be maintained after premature 426 
delivery since kidney weight significantly correlated with glomerular number in the 427 
preterm baboons.  However, in the present study our linear regression analyses 428 
indicate that glomerular density (the number of glomeruli per gram of kidney) is 429 
substantially less in the preterm kidneys (83,840 glomeruli/gram) compared to 430 
gestational controls (193,400 glomeruli/gram); this is likely to be due to the relative 431 




glomeruli formed.  Further studies would be necessary in order to investigate whether 433 
this difference in glomerular density reflects a change in renal tubular mass.       434 
 435 
Our findings have demonstrated that antenatal exposure to glucocorticoids prior to 436 
preterm birth increases the number of developed glomeruli within the preterm baboon 437 
kidney.  Certainly, this indicates that glucocorticoid administration has accelerated 438 
glomerular maturation, which is in accordance with previous studies demonstrating 439 
that glucocorticoids induce organ maturation (13).  Our findings also support the 440 
improvement in renal function demonstrated to occur in preterm infants exposed to 441 
steroids (1).  Exposure to steroids also resulted in a greater increase in kidney weight-442 
to-body weight ratio, suggesting that glucocorticoid treatment may be leading to renal 443 
hypertrophy.  Previous studies in the preterm lamb, baboon and human neonate have 444 
shown that glucocorticoid treatment increases mean arterial pressure, renal blood flow 445 
and glomerular filtration rate, implicative of renal functional maturation, (1, 10, 35) 446 
which may be contributing to the renal hypertrophy observed in the current study.  447 
Indeed, mean arterial blood pressure was observed to be significantly elevated at 72 448 
hours of life in the preterm baboons exposed to antenatal steroids.  Similar findings 449 
have also been reported in human infants, in which the effects of prenatal 450 
glucocorticoids appear to be limited to the early postnatal period (1, 37). 451 
 452 
In accordance with previous studies (31, 36) abnormal glomeruli exhibiting a dilated 453 
Bowman’s space surrounding an underdeveloped glomerular tuft were observed in the 454 
outer renal cortex of both steroid exposed and unexposed preterm kidneys, suggesting 455 
glomeruli formed in the extra-uterine environment are ‘at risk’;  developed glomeruli 456 




direct consequence of premature birth and/or treatments in the postnatal care of the 458 
preterm neonate, since the number of abnormal glomeruli in the gestational control 459 
kidneys was negligible.  Immunostaining with the endothelial cell marker, CD31 460 
showed that the abnormal glomeruli in the preterm kidneys were poorly vascularised, 461 
even though VEGF was expressed.  The abnormal glomeruli appeared to be in a 462 
relatively immature state of development with a layer of WT-1 positive epithelial cells 463 
(indicative of podocytes) surrounding a spherical mass of relatively undifferentiated 464 
cells.  Positive WT-1 immunostaining was also localised to the epithelial cells of the 465 
Bowman’s capsule (parietal podocytes), which has been demonstrated previously in 466 
the human kidney (2).  Interestingly, Bariety et al. (2) noted that capsules without a 467 
glomerular tuft, or a retracted tuft, contained a greater number of parietal podocytes 468 
compared to normal glomeruli, lining the entirety of the Bowman’s capsule.  469 
Furthermore, Gibson et al. (14), have also shown that in atubular cystic glomeruli in 470 
human kidneys, the Bowman’s capsule is always lined by parietal podocytes.  It is 471 
therefore conceivable that the cystic abnormal glomeruli observed in the preterm 472 
kidneys may be atubular, and as such would never be functional.  473 
 474 
Not all kidneys from the premature baboons contained the same proportion of 475 
abnormal glomeruli, ranging from 0.2% to as high as 18%.  Hence, preterm birth may 476 
not always adversely impact on kidney development, or alternatively there may be a 477 
difference in the rates of resorption of dysfunctional glomeruli (26).  Another likely 478 
explanation is that factors in the postnatal care of the neonate (which varies between 479 
neonates) adversely impact on nephrogenesis.  In particular, pharmacological agents 480 
administered to the neonate in the postnatal period,  such as aminoglycoside 481 




preterm neonates were exposed to antibiotics after birth, it is possible that the 483 
glomerular abnormalities in the kidneys have been caused by exposure to nephrotoxic 484 
antibiotics.  However, if this is the case, it is difficult to explain why there was such a 485 
variation in the proportion of abnormal glomeruli within the preterm kidneys given 486 
that all neonates received the same regime of antibiotics, except for two animals that 487 
were administered additional doses; these animals were not the neonates with the high 488 
proportion of abnormal glomeruli. Further studies are required to elucidate whether 489 
exposure to antibiotics is nephrotoxic to the preterm infant and/or whether other 490 
medications, or factors in the postnatal care of the preterm infants lead to the adverse 491 
renal effects that we observe.  If definitive associations are found, this may lead to 492 
potential interventions to improve the renal health of preterm babies.            493 
 494 
In conclusion, using a non-human primate model the current study has clearly 495 
demonstrated on-going nephrogenesis after preterm birth.  The rate of glomerular 496 
formation remains similar following preterm birth; however, glomerular density 497 
(number of glomeruli per gram of kidney) was significantly reduced in the preterm 498 
kidney suggesting that the non-glomerular compartments are growing at a faster rate.  499 
Of concern, many preterm neonates exhibited abnormal glomeruli in the outer renal 500 
cortex suggesting that extra-uterine nephrogenesis leads to an increased risk of 501 
abnormal glomerular development.  Whether this will impact on final nephron 502 
endowment is yet to be determined, since nephrogenesis was still on-going. 503 
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Figure Legends 653 
Figure 1:  (A) Representative photomicrographs of kidney sections from the 125 (top 654 
panel) and 146 (middle panel) day gestational control groups and the Preterm + 21 655 
days group (bottom panel)  all demonstrating evidence of on-going nephrogenesis in 656 
the outer renal cortex (NZ=nephrogenic zone, C=Comma-shaped body, UB=ureteric 657 
bud).  (B)  Nephrogenic zone thickness of gestational controls (125 days gestation and 658 
146 days gestation) compared to the Preterm + 21 days group.  Data was analysed 659 
using a one-way analysis of variance followed by a Tukey’s Post-Hoc Analysis.  660 
Nephrogenic zone thickness in the 125 day gestational controls were significantly 661 
greater (*P<0.05) compared to the 146 day gestational controls and the Preterm + 21 662 
days group  (C) The number of glomerular generations in the gestational controls (125 663 
days gestation, 146 days gestation, 175/185 days gestation) compared to the Preterm + 664 
21 days group.   Data was analysed using a one-way analysis of variance followed by 665 
a Tukey’s Post-Hoc Test.  The number of glomerular generations was significantly 666 
greater in the 125 day gestational controls compared to the 146 day and 175/185 day 667 
gestational controls and the Preterm + 21 days group (*P<0.0001) (D)  Linear 668 
regression analysis of glomerular number versus post-conceptional age in preterm 669 
kidneys showing a significant linear relationship between post-conceptional age and 670 
glomerular number.  (E)  Linear regression analysis of glomerular generations versus 671 
post-conceptional age in preterm kidneys showing a significant linear relationship 672 
between post-conceptional age and the number of glomerular generations.   673 
 674 
Figure 2:  Linear regression analyses of glomerular number versus kidney weight in 675 
preterm neonates (circles) and gestational controls (triangles).   There was a 676 




the preterm neonates and gestational controls (P<0.05).   An analysis of covariance 678 
demonstrated a significant difference in the slopes of the two regression lines 679 
(P=0.048). 680 
 681 
Figure 3:  (A) Fluid intake, (B) urine output and (C) mean arterial blood pressure of 682 
the Preterm + 21 days group; n=4 compared to the Preterm + 21 days + steroids 683 
group; n=4.  Steroid exposed neonates are represented in squares and unexposed 684 
controls are in circles.  Data was analysed using a repeated measures two-way 685 
analysis of variance followed by a Bonferroni’s Post-Hoc analysis.  At 72 hours of 686 
life, mean arterial blood pressure was significantly higher in the steroid exposed 687 
animals compared to unexposed controls (*P<0.05).    688 
 689 
Figure 4:  Representative photomicrographs of kidney sections from the 146 day 690 
gestational control group and  the Preterm + 21 days group immunostained with (A) 691 
an endothelial cell marker(CD31), (B) the Wilm’s tumour suppressor gene-1 (WT-1), 692 
and (C) in situ hybridization for vascular endothelial growth factor (VEGF).  The 693 
glomeruli from the 146 day gestational control group show profuse positive brown 694 
staining for CD31 (A).  The abnormal glomeruli in the Preterm + 21 days group are 695 
poorly vascularized as shown by the scant positive brown staining for CD31 (A).  696 
WT-1 positive staining is localized to podocytes within the glomerular tuft of 697 
developed, normal glomeruli (B).  In abnormal glomeruli, WT-1 staining is localized 698 
to podocytes surrounding the immature glomerular anlage (B).  WT-1 positive 699 
immunostaining can also be observed in the parietal epithelial cells of the Bowman’s 700 
capsule (arrows).  VEGF positive immunostaining (dark purple staining) was 701 




glomerulus from a preterm kidney, VEGF positive podocytes stained dark purple 703 















Table 1:  Birth weights, necropsy weights, kidney weights, kidney volumes, kidney weight to body weight ratios, kidney volume to kidney 716 
weight ratios, glomerular number and mean renal corpuscle volume of gestational controls at 125 days gestation and 146 days gestation and 717 
preterm neonates at postnatal day 21 (analyzed using a one-way analysis of variance followed by a Tukey’s Post-Hoc analysis). 718 
   719 
 Gestational  Controls Preterm 
 125 days (n=4) 146 days (n=4) Preterm + 21 days (n=4)
Birth weight (g) 353 ± 12
# 
(329 – 375) 
597 ± 25* 
(532 – 654) 
419 ± 22# 
(354 – 460) 
Necropsy weight (g) 353 ± 12
# 
(329 – 375) 
597 ± 25* 
(532 – 654) 
400 ± 30# 
(320 - 466) 
Kidney weight (g) 1.37 ± 0.16 (1.01 – 1.77) 
1.82 ± 0.18 
(1.31 – 2.16) 
2.73 ± 0.41*
(1.90 – 3.87) 
Kidney volume (mm3) 903 ± 113 (636 – 1170) 
1348 ± 196 
(819 – 1768) 
1719 ± 270 
(1391 – 2523) 
Kidney weight-to-body 
weight ratio (g/kg) 
3.9 ± 0.5 
(2.7 – 5.4) 
3.1 ± 0.4 
(2.0 – 3.7) 
6.7 ± 0.5*# 
(5.9 – 8.3) 
Kidney volume-to-body 
weight ratio (mm3/g) 
2.6 ± 04 
(1.7 – 3.6) 
2.3 ± 0.4 
(1.2 – 3.0) 
4.3 ± 0.4*# 
(3.5 – 5.4) 
Glomerular number 117,235 ± 8,766 (101,439 – 137,765) 
270,486 ± 33,631* 
(202,266 – 352,621) 
283,535 ± 12,358* 
(249,772 – 304186) 
Average renal corpuscle 
volume x 10-4 (mm3) 
5.87 ± 0.52 
(5.03 – 7.38) 
3.97 ± 0.35 
(2.37 – 4.29) 
3.65 ± 0.43 
(3.14 – 4.72) 
 720 
All animals were exposed to antenatal glucocorticoids 721 
Data presented as mean ± SEM with data range in parentheses.    722 




Table 2:  Arterial blood gases (pH, PaCO2, PaO2) of the Preterm + 21 days group compared to the 724 




Preterm + 21 days 
(n=4) 
Preterm + 21 days          
+ steroids (n=4) 
pH 7.32 ± 0.03 7.29 ± 0.03 
PaCO2 
(mmHg) 47.7 ± 4.5 53.2 ± 1.9 
PaO2 
(mmHg) 79.7 ± 0.3 67.0 ± 6.4 
 728 




Table 3:  Birth weights, necropsy weights, kidney weights, kidney volumes, kidney weight to body weight ratios, glomerular generation 730 
number, glomerular number and mean renal corpuscle volume of preterm  neonates at 125 days gestation and at postnatal day 21.  Neonates at 731 
each time-point were exposed to maternal betamethasone treatment at 123 and 124 days gestation (+ steroids; data as shown in Table 2) or were 732 
unexposed (- steroids).  Data was analysed using a two-way analysis of variance. 733 





125 days gestation 
+  steroids 
(n=4) 
Preterm + 21 days 
- steroids 
 (n=4) 










age x Steroid 
treatment
Birth weight (g) 375 ± 25 (299 - 448) 
353 ± 12 
(329 – 375)
414 ± 28 
(373 – 496) 
419 ± 22 
(354 – 460)
P = 0.05 P = 0.733 P = 0.589 
Necropsy weight (g) 375 ± 25 (299 - 448)
353 ± 12 
(329 – 375)
395 ± 15.4 
(363 – 436) 
400 ± 30 
(320 - 466)
P > 0.05 P > 0.05 P > 0.05 
Kidney weight (g) 0.917 ± 0.10 (0.559 - 1.21)
1.37 ± 0.16 
(1.01 – 1.77)
2.31 ± 0.17 
(1.89 – 2.64) 
2.73 ± 0.41 
(1.90 – 3.87)
P < 0.0001 P > 0.05 P > 0.05 
Kidney volume (mm3) 548 ± 48 (391 – 660) 
903 ± 113 
(636 – 1170)
1690 ± 200 
(1352 - 2164) 
1718 ± 270 
(1391 – 2523)
P < 0.0001 P > 0.05 P > 0.05 
Kidney weight-to-body 
weight ratio (g/kg) 
2.5 ± 0.3 
(1.5 – 3.6) 
3.9 ± 0.5 
(2.7 – 5.4)
5.9 ± 0.3 
(5.2 – 6.5) 
6.7 ± 0.5 
(5.9 – 8.3)
P < 0.0001 P = 0.02 P > 0.05 
Glomerular 
Generations 
7 ± 0.2 
(6 – 7)
7 ± 0.1 
(7 – 8)
10 ± 0.2 
(10 – 11) 
10 ± 0.6 
(8 -11)
P < 0.0001 P = 0.6 P > 0.05 
Glomerular number 105,632 ± 10173 (63,385 - 126,697) 
117,235  ± 8,766 
(101,439 – 137,765)
207,810 ± 35,384
(138,078 - 272,085) 
283,535 ± 12,358
(249,772 – 304186)
P < 0.0001 P = 0.03 P = 0.1 
Average Renal 
Corpuscle Volume x 10-
4 (mm3) 
3.79 ± 0.45 
(2.49 – 5.59) 
5.87 ± 0.52 
(5.03 – 7.38) 
5.32 ±  0.43 
(4.24 – 6.22) 
3.65 ± 0.43 
(3.14 – 4.72) P = 0.7 P = 0.5 P = 0.001 


















Animals from the 125 days gestation, 146 days gestation and Preterm + 21 days groups were all exposed to antenatal glucocorticoids. 749 
Data presented as mean ± SEM 750 
751 




125 days 146 days  
175/185 
days 
Preterm + 6 
days 
Preterm + 14 
days 
Pre-term + 21 
days 
 1.3 0.2 0.0 4.3 10.7 18.3 
Proportion 1.2 0.0 0.0 6.5 6.1 1.4 
of abnormal 0.3 0.0 0.0   2.0 
glomeruli 
(%) 
2.4 0.0 0.0   2.6 
   0.0    
       












Preterm + 21 days 
- steroids 
Preterm + 21 days 
+ steroids 
 0.2 1.3 0.2 18.3 
Proportion 2.9 1.2 12.8 1.4 
of abnormal 0.6 0.3 0.2 2.0 
glomeruli (%) 0.2 2.4 4.7 2.6 
 0.5    
 0.0    
Average 0.7 ± 0.4 % 1.3 ± 0.4% 4.5 ± 3.0% 6.1 ± 4.1% 
 753 
































































































































































































































PRETERM + 21 DAYS
B
146 DAY GESTATIONAL 
CONTROL
C
